Investment Options

Investment Options in the context of an employer-sponsored 401(k) refers to the array of financial vehicles available for employees to allocate their retirement savings. Within a 401(k) plan, employees have the opportunity to invest their contributions into various assets, allowing them to build a diversified portfolio tailored to their risk tolerance and long-term financial goals.

Examples of investment options commonly found in 401(k) plans include:

  • Mutual Funds: These are professionally managed funds that pool money from multiple investors to invest in a diversified range of stocks, bonds, or other securities. Mutual funds offer varying levels of risk and potential returns, making them popular choices for 401(k) participants seeking broad exposure to the market.
  • Target-Date Funds: These funds automatically adjust their asset allocation based on the target retirement date. As the employee approaches retirement, the fund gradually shifts from higher-risk to more conservative investments, reducing exposure to volatility over time.
  • Index Funds: Index funds aim to replicate the performance of a specific market index, such as the S&P 500. They offer a passive investment approach, often with lower fees than actively managed funds, and are suitable for those seeking a "set-it-and-forget-it" investment strategy.

Understanding the available investment options is crucial for employees to make informed decisions about how to grow their retirement savings effectively. Employers typically provide investment education resources to assist participants in navigating these choices and creating a well-balanced 401(k) portfolio

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.